Lessons Learned from N-of-1 Trials
Author Information
Author(s): Wegman Anke CM, van der Windt Daniëlle AWM, Stalman Wim AB, de Vries Theo PGM
Primary Institution: VU University medical center
Hypothesis
Can N-of-1 trials help in making treatment decisions for individual patients?
Conclusion
N-of-1 trials can be tailored to individual patients, helping to overcome difficulties in treatment decision-making.
Supporting Evidence
- N-of-1 trials provide more objective evidence of individual benefit or harm.
- Individualized outcome measures can lead to high completion rates.
- Patients found it easy to answer questions reflecting their main problems.
Takeaway
N-of-1 trials are like personal experiments where doctors test different treatments on one patient to see what works best for them.
Methodology
Two series of double-blind randomized N-of-1 trials were conducted in general practice, focusing on patients with osteoarthritis and long-term users of temazepam.
Potential Biases
Potential biases include patient expectations influencing perceived efficacy and withdrawal rates due to perceived lack of efficacy.
Limitations
The methodology of N-of-1 trials is not as firmly established as that of RCTs, and reports are still relatively scarce.
Participant Demographics
Patients included those with osteoarthritis and long-term users of temazepam.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website